Biochemical and pharmacological studies on pramipexole, a potent and selective dopamine D2 receptor agonist
- 1 May 1992
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 215 (2-3) , 161-170
- https://doi.org/10.1016/0014-2999(92)90024-x
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Pramipexole, a dopamine D2 autoreceptor agonist, decreases the extracellular concentration of dopamine in vivoEuropean Journal of Pharmacology, 1991
- D-2 dopamine autoreceptor selective drugs: Do they really exist?Life Sciences, 1990
- B-HT 920 is a full agonist at both pre- and postsynaptic D-2 dopamine receptorsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1990
- Effects of B‐HT 920 on nigrostriatal and mesolimbic dopamine systems in normosensitive and supersensitive ratsBritish Journal of Pharmacology, 1990
- Cloning and expression of a rat D2 dopamine receptor cDNANature, 1988
- Alkylation of striatal dopamine receptors abolishes stereotyped behavior but has no effect on dopamine stimulated adenylate cyclase activityNeuroscience Letters, 1988
- Synergistic interaction between dopamine D-1 and D-2 receptor agonists: circling behaviour of rats with hemitransectionEuropean Journal of Pharmacology, 1987
- Dopaminergic mechanisms and motor function: Characterization of D-1 and D-2 dopamine receptor interactionsEuropean Journal of Pharmacology, 1986
- Postsynaptic dopamine agonistic effects of 3-PPP enantiomers revealed by bilateral 6-hydroxy-dopamine lesions and by chronic reserpine treatment in ratsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1984
- Effect of Chlorpromazine or Haloperidol on Formation of 3‐Methoxytyramine and Normetanephrine in Mouse BrainActa Pharmacologica et Toxicologica, 1963